
PRLD Market Cap & Key Metrics
Prelude Therapeutics Incorporated
$3.32
-$0.09(-2.64%)
34
Overall
60
Value
20
Tech
23
Quality
Market Cap
$264.95M
Volume
422.31K
52W Range
$1.30 - $6.83
Target Price
$9.00
PRLD market cap is $264.95M. This page lists Prelude Therapeutics Incorporated's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
PRLD Key Metrics
- Market cap
- $264.95M
- EPS estimate, current year
- $-0.57
- EPS growth, 3-year
- +23.77%
- Value score
- 60
- Quality score
- 23
- Technical score
- 20
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $7.00M | - | - | - | - |
| EBITDA | -$123.81M | -$118.73M | -$122.22M | -$112.82M | -$58.22M |
| EPS | $-1.68 | $-2.02 | $-2.44 | $-2.43 | $-4.56 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $3.32 | -2.6% | 422.31K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW